(Sharecast News) - Proteome Sciences said on Monday that it had secured a further significant clinical contract linked to its target engagement and chemoproteomics platform.
See latest RNS on InvestegateThe AIM-traded company said it expected the contract to act as a precursor to a new clinical trial programme due to start later in 2026.
Executive chairman Christopher Pearce said momentum and growth in Proteome's chemoproteomics services was continuing this year, adding that the company had generated "considerable interest and attention" at the recent American Society for Mass Spectrometry meeting in San Diego.
At 1016 BST, shares in Proteome Sciences were up 9.27% at 1.65p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
Market News

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...


* Rising bets on Fed hikes keep yen near 40-year lows


* Mining sector leads declines; FTSE midcap at June 11 level


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.


(Sharecast News) - Proteome Sciences said on Monday that it had secured a further significant clinical contract linked to its target engagement and ch...


(Alliance News) - Stock prices in London were mixed at midday on Monday, after UK Prime Minister Keir Starmer announced his resignation and mediators ...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday.


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.